4d Molecular Therapeutics In shares owned by Geode Capital Management
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Geode Capital Management
from 13F filings
Historical chart of Geode Capital Management investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Geode Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $11M | 1.0M | 10.81 |
| 2024-06-30 | $22M | 1.1M | 20.99 |
| 2024-03-31 | $28M | 873k | 31.86 |
| 2023-09-30 | $9.4M | 742k | 12.73 |
| 2023-06-30 | $13M | 690k | 18.07 |
| 2023-03-31 | $9.9M | 578k | 17.19 |
| 2022-12-31 | $13M | 562k | 22.21 |
| 2022-09-30 | $4.3M | 529k | 8.04 |
| 2022-06-30 | $3.4M | 493k | 6.98 |
| 2022-03-31 | $7.2M | 479k | 15.12 |
| 2021-12-31 | $11M | 482k | 21.94 |
| 2021-09-30 | $9.2M | 342k | 26.97 |
| 2021-06-30 | $4.0M | 167k | 24.08 |
| 2021-03-31 | $6.3M | 146k | 43.38 |
| 2020-12-31 | $529k | 13k | 41.39 |